Matt, Author at European Medical Journal - Page 89 of 212

Continue
2 Mins
5 Nov 2019

Once-Weekly Semaglutide versus Daily Canagliflozin in Type 2 Diabetes Mellitus (SUSTAIN 8): How Do They Compare?

Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium–glucose cotransporter-2 inhibitors (SGLT-2i) are effective and well-tolerated…
10 Mins
5 Nov 2019

Feasibility of a Diabetes Prevention Programme as Part of Cancer Survivorship Care

There are currently 14 million cancer survivors in the USA, a number that is expected to increase as the population ages…
2 Mins
5 Nov 2019

SUSTAIN 10: Efficacy and Safety of Semaglutide 1.0 mg Once Weekly versus Liraglutide 1.2 mg Once Daily

Subcutaneous semaglutide once weekly (OW) and subcutaneous liraglutide once daily (OD) are two glucagon-like peptide-1 receptor agonists (GLP-1RA)…
2 Mins
5 Nov 2019

Deep Serum Proteomics Reveal Biomarkers and Causal Candidates for Type 2 Diabetes Mellitus

The prevalence of Type 2 diabetes mellitus  (T2DM) is expected to increase rapidly in the next decades, posing a major challenge to societies worldwide.
9 Mins
5 Nov 2019

Multidisciplinary Approach to Management and Care of Patients with Type 2 Diabetes Mellitus

This article discusses the key studies that changed the way T2DM is managed to incorporate an interdisciplinary approach to care, the principles of the multidisciplinary teams, examples of multidisciplinary teams in real-world clinical practice, and associated patient outcomes.
8 Mins
5 Nov 2019

Knowledge, Practices, and Risk of Diabetic Foot Syndrome Among Diabetic Patients in a Tertiary Care Hospital in Bengaluru, India

India has been called the ‘diabetic capital of the world’ because of the predominant Westernisation of its inhabitants, which includes people of different…
2 Mins
5 Nov 2019

Effect of the Time of Day of Food Intake and Eating Occasions on Clock Gene mRNA Expression, Weight Loss, HbA1c, and Overall Glycaemia in Type 2 Diabetes Mellitus

Most of the metabolic processes involved in obesity, glycaemic control (i.e., β-cell function), muscular glucose uptake, and hepatic glucose production…
6 Mins
5 Nov 2019

Evaluation of The Relationship Between Glycaemic Regulation Parameters and Neutrophil-to-Lymphocyte Ratio in Type 2 Diabetic Patients

Diabetes mellitus (DM) is an important public health problem with a gradually increasing prevalence in the authors’ country and worldwide…
11 Mins
5 Nov 2019

Pathophysiology of Gestational Diabetes Mellitus

Gestational diabetes mellitus (GDM) is a pregnancy complication defined as a glucose intolerance of varying severity with onset or first recognition during pregnancy.
7 Mins
5 Nov 2019

Implication of the MAPK Signalling Pathway in the Pathogenesis of Diabetic Nephropathy

Diabetic nephropathy (DN) is considered the most common microvascular complication of diabetes, being a major cause of end-stage renal disease (ESRD)…
We’ve noticed you’re accessing
from North/South America.